“…These issues may arise due to the molecular weight of the antigen, its charge, or other sequence peculiarities, including repeats, pseudo-termination sequences, or rare tRNA codons. To address these, various strategies have been developed, including the expression of mosaic VLPs [ 54 , 55 , 56 , 57 , 58 , 59 ], or the binding of antigens by chemical [ 39 , 60 , 61 , 62 , 63 , 64 , 65 ], enzymatic [ 57 , 66 , 67 , 68 , 69 ], or physical [ 70 , 71 , 72 , 73 ] methods.…”